NCT04614467Phase 2Terminated

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Study sponsor: Lisata Therapeutics, Inc. · LSTA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-09-28Actual
Enrollment · participants34Actual
Source updated2026-05-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change From Baseline in Angina Frequency Measure: Change From Baseline in CCS Angina Class Measure: Change From Baseline in Total Exercise Time Measure: Change From Baseline in Health-related Quality of Life (HRQoL). After: Measure: Change From Baseline in Number of Angina Attacks Per Week Measure: Change From Baseline in CCS Angina Class Measure: Change From Baseline in Total Exercise Time Measure: Change From Baseline in Health-related Quality of Life (HRQoL).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview